Latest Retinoids Stories

WASHINGTON (Reuters) - Patients and doctors must register with manufacturers before using or prescribing Roche Holding AG's acne drug Accutane or its generic versions, U.S. regulators said on Friday. The requirement is part of a plan to strengthen safeguards meant to keep pregnant women from taking Accutane, the Food and Drug Administration said in a statement. The drug can cause birth defects. The FDA also said it approved changes to existing warnings "so that patients and...